224 related articles for article (PubMed ID: 25066378)
1. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
[TBL] [Abstract][Full Text] [Related]
2. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
3. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer.
Tan IB; Malik S; Ramnarayanan K; McPherson JR; Ho DL; Suzuki Y; Ng SB; Yan S; Lim KH; Koh D; Hoe CM; Chan CY; Ten R; Goh BK; Chung AY; Tan J; Chan CX; Tay ST; Alexander L; Nagarajan N; Hillmer AM; Tang CL; Chua C; Teh BT; Rozen S; Tan P
Genome Biol; 2015 Feb; 16(1):32. PubMed ID: 25808843
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
[TBL] [Abstract][Full Text] [Related]
7. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
[TBL] [Abstract][Full Text] [Related]
8. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis.
Liu J; Cho YB; Hong HK; Wu S; Ebert PJ; Bray SM; Wong SS; Ting JC; Calley JN; Whittington CF; Bhagwat SV; Reinhard C; Wild R; Nam DH; Aggarwal A; Lee WY; Peng SB
Sci Rep; 2020 Jul; 10(1):10725. PubMed ID: 32612211
[TBL] [Abstract][Full Text] [Related]
10. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Kothari N; Teer JK; Abbott AM; Srikumar T; Zhang Y; Yoder SJ; Brohl AS; Kim RD; Reed DR; Shibata D
Cancer; 2016 Sep; 122(18):2828-35. PubMed ID: 27244218
[TBL] [Abstract][Full Text] [Related]
12. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.
Malapelle U; Pisapia P; Sgariglia R; Vigliar E; Biglietto M; Carlomagno C; Giuffrè G; Bellevicine C; Troncone G
J Clin Pathol; 2016 Sep; 69(9):767-71. PubMed ID: 26797410
[TBL] [Abstract][Full Text] [Related]
13. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors.
Furuta M; Ueno M; Fujimoto A; Hayami S; Yasukawa S; Kojima F; Arihiro K; Kawakami Y; Wardell CP; Shiraishi Y; Tanaka H; Nakano K; Maejima K; Sasaki-Oku A; Tokunaga N; Boroevich KA; Abe T; Aikata H; Ohdan H; Gotoh K; Kubo M; Tsunoda T; Miyano S; Chayama K; Yamaue H; Nakagawa H
J Hepatol; 2017 Feb; 66(2):363-373. PubMed ID: 27742377
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
[TBL] [Abstract][Full Text] [Related]
15. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
[TBL] [Abstract][Full Text] [Related]
16. Exome scale map of genetic alterations promoting metastasis in colorectal cancer.
Goryca K; Kulecka M; Paziewska A; Dabrowska M; Grzelak M; Skrzypczak M; Ginalski K; Mroz A; Rutkowski A; Paczkowska K; Mikula M; Ostrowski J
BMC Genet; 2018 Sep; 19(1):85. PubMed ID: 30231850
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
18. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
[TBL] [Abstract][Full Text] [Related]
19. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
[TBL] [Abstract][Full Text] [Related]
20. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
